Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
6941
-
6942
Related to Fig 2.
Published 2025“…(<b>C</b>) Cell proliferation studies show a decrease in the proliferation of BT-474_RICTOR<sup>SH</sup> cells (mean ± SEM, <i>n</i> = 3) compared to BT-474_SCRAM<sup>SH</sup> cells. …”
-
6943
Average wellness for matchday, MD
Published 2025“…<div><p>Background</p><p>Exposure to match loads significantly affects physiological and psychological indicators and, consequently, players’ wellness. …”
-
6944
RICTOR silencing inhibits cell proliferation via UGCG regulation.
Published 2025“…(<b>C</b>) Cell proliferation studies show a decrease in the proliferation of MCF-7_RICTOR<sup>SH</sup> cells (mean ± SEM, <i>n</i> = 4) compared to MCF-7_SCRAM<sup>SH</sup> cells. …”
-
6945
The RehaGait® system.
Published 2025“…</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”
-
6946
Flow chart of included patients and dropouts.
Published 2025“…</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”
-
6947
Dataset of the analyzed data.
Published 2025“…</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”
-
6948
-
6949
ERI Thresholds Between Adjacent Zones.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6950
Location of the study area.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6951
Random Forest structure with cross-validation.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6952
Land use change from 1990 to 2020.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6953
Geographic data.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6954
Classification accuracy.
Published 2025“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”
-
6955
Effects and Potential Risks of Chiral Penflufen on Pickled Cowpea: Combined Microbiome and Metabolomics
Published 2025“…<i>S</i>-Penflufen reduced alcohols and increased esters more significantly, and altered a higher number of volatile organic compounds (VOCs) and chiral amino acids than <i>R</i>-penflufen, showing a greater risk to food flavor and nutritional quality.…”
-
6956
BrdU assay in control siRNA (blue bars) and in PAX6 knockdown (red bars) limbal epithelial cells (LECs) without and after 1µM or 5µM RA incubation for 48 hours.
Published 2025“…<p>Two-way ANOVA, followed by Dunnett’s test was used. Significant p values (<0.05) are highlighted. BrdU assay shows a significantly lower proliferation rate in the PAX6 siRNA knockdown group than in control siRNA group (p < 0.001). 5µM RA treatment significantly decreased proliferation rate in controls (p = 0.025). …”
-
6957
Related to Fig 3.
Published 2025“…(<b>Q</b>) Tumor growth kinetics recorded a significantly higher growth of BT-474_ZFX<sup>OE</sup> (mean ± SEM, <i>n</i> = 5) than BT-474_VECT<sup>OE</sup> tumors. …”
-
6958
-
6959
-
6960